Compare Lustrum:Oncolys BioPharma Inc.:4588

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Oncolys BioPharma Inc. 4588 Medicals 東証グロース December 1, 2000 2013.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Oncolys BioPharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Oncolys BioPharma Inc. Balance Sheet 2023年12月期 Oncolys BioPharma Inc. Balance Sheet 2022年12月期 Oncolys BioPharma Inc. Balance Sheet 2021年12月期 Oncolys BioPharma Inc. Balance Sheet 2020年12月期 Oncolys BioPharma Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
1,533down
(75.1%)up
1,711down
(64.6%)down
3,455up
(80.5%)up
2,068down
(73.9%)down
3,343
(76.3%)
Other Current AssetsHelp
(Percent)
423down
(20.7%)down
897up
(33.9%)up
743up
(17.3%)up
478down
(17.1%)up
484
(11.0%)
Tangible Fixed AssetsHelp
(Percent)
0
-
0
-
0
-
21up
(0.8%)up
12
(0.3%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
1
(0.0%)
0
-
Investments and OthersHelp
(Percent)
85up
(4.2%)up
42down
(1.6%)down
94down
(2.2%)down
229down
(8.2%)down
542
(12.4%)
Total AssetsHelp
(Percent)
2,041
(100%)
2,651
(100%)
4,292
(100%)
2,796
(100%)
4,380
(100%)
Total Current LiabilitiesHelp
(Percent)
387up
(18.9%)up
329down
(12.4%)up
436up
(10.2%)down
420down
(15.0%)up
529
(12.1%)
Total Long-term LiabilitiesHelp
(Percent)
180up
(8.8%)up
162down
(6.1%)up
262down
(6.1%)down
373down
(13.3%)up
397
(9.1%)
Shareholder's EquityHelp
(Percent)
1,474down
(72.2%)down
2,159down
(81.5%)down
3,594up
(83.7%)up
2,003down
(71.6%)down
3,454
(78.9%)
Total LiabilitiesHelp
(Percent)
2,041
(100%)
2,651
(100%)
4,292
(100%)
2,796
(100%)
4,380
(100%)

Oncolys BioPharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Oncolys BioPharma Inc. Profit and Loss Account 2023年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2022年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2021年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2020年12月期 Oncolys BioPharma Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
63
(100%)
976
(100%)
642
(100%)
314
(100%)
1,304
(100%)
Total Sales
(Percent)
63
(100%)
976
(100%)
642
(100%)
314
(100%)
1,304
(100%)
Cost of SalesHelp
(Percent)
32down
(51.4%)down
638up
(65.3%)down
444up
(69.1%)up
78down
(24.8%)up
113
(8.7%)
Other Costs and RevenueHelp 1,969up
(3,123.7%)up
1,487down
(152.4%)down
1,814down
(282.4%)down
2,331up
(742.0%)up
2,103
(161.3%)
Total CostsHelp 2,002 2,125 2,258 2,409 2,216
Net RevenueHelp 31down
(48.6%)up
338up
(34.7%)up
199down
(30.9%)down
236down
(75.2%)down
1,191
(91.3%)
Earnings Before TaxHelp -1,936down
(-3,070.5%)down
-1,146up
(-117.4%)up
-1,612up
(-250.9%)up
-2,091down
(-665.7%)down
-909
(-69.7%)
Net IncomeHelp -1,939down
(-3,075.1%)down
-1,149up
(-117.7%)up
-1,615up
(-251.4%)up
-2,095down
(-666.8%)down
-912
(-70.0%)
当期純利益 -1,939 -1,149 -1,615 -2,095 -912

Oncolys BioPharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Oncolys BioPharma Inc. Cash Flow Statement 2023年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2022年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2021年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2020年12月期 Oncolys BioPharma Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,337up
(-99.6%)down
-1,717up
(-93.8%)down
-1,742down
(-55.7%)up
-1,465down
(-96.6%)down
-238
(-21.2%)
Investing Cash Flow(ICF)Help
(Percent)
-5down
(-0.4%)down
20up
(1.1%)up
-1up
(0.0%)up
-38down
(-2.5%)down
-4
(-0.4%)
Financing Cash FlowHelp
(Percent)
1,143up
(85.1%)up
-114down
(-6.2%)down
3,091up
(98.8%)up
242down
(16.0%)down
1,123
(100.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
21down
(1.6%)down
67up
(3.7%)up
38up
(1.2%)up
-14down
(-0.9%)down
-1
(-0.1%)
Net Increase and Decrease in Cash and Cash Equivalentsn -178up
(-13.3%)up
-1,743down
(-95.2%)down
1,387up
(44.3%)up
-1,275down
(-84.0%)down
879
(78.3%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Oncolys BioPharma Inc.

Company where related level is highHelp

NIPPON CHEMIPHAR CO.,LTD.
Takeda Pharmaceutical Company Limited
Nissui Pharmaceutical Co.,Ltd.
STELLA PHARMA CORPORATION
KYORIN Pharmaceutical Co., Ltd.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
Astellas Pharma Inc.
Modalis Therapeutics Corporation
Solasia Pharma K.K.
SAWAI PHARMACEUTICAL CO.,LTD.